Drug Interactions between Cycrin and etretinate
This report displays the potential drug interactions for the following 2 drugs:
- Cycrin (medroxyprogesterone)
Interactions between your drugs
Applies to: Cycrin (medroxyprogesterone) and etretinate
Using etretinate and medroxyPROGESTERone is not recommended. Etretinate can cause severe, life-threatening birth defects if the mother takes the medication during pregnancy. Never use etretinate if you are pregnant. Both a primary and a secondary form of birth control must be used together and for at least 3 years after stopping therapy. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor. Taking these drugs can interfere with the contraceptive effect of medroxyPROGESTERone. Because use of etretinate is associated with major birth defects, microdosed 'minipill' progestin preparations are not recommended for women of childbearing potential treated with etretinate. The use of at least two methods of effective contraception is mandatory during etretinate therapy and for at least 3 years after stopping therapy. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
No interactions were found. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.